Steffan T Nawrocki

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Metabolic Syndrome

Top Venues

Cancer research communications

Clinical cancer research : an official journal of the American Association for Cancer Research

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Trace M Jones, Claudia M Espitia, Juan J Chipollini, Benjamin R Lee, Jason A Wertheim, Jennifer S Carew, Steffan T Nawrocki
Targeting NEDDylation is a Novel Strategy to Attenuate Cisplatin-induced Nephrotoxicity. Cancer research communications 3 (2) (2023)
Trace M Jones, Claudia M Espitia, Juan J Chipollini, Benjamin R Lee, Jason A Wertheim, Jennifer S Carew, Steffan T Nawrocki
Targeting NEDDylation is a Novel Strategy to Attenuate Cisplatin-induced Nephrotoxicity. Cancer research communications 3 (2) (2023)
Steffan T Nawrocki, Julian Olea, Claudia Villa Celi, Homa Dadrastoussi, Kaijin Wu, Denice Tsao-Wei, Anthony R Colombo, Matthew Coffey, Eduardo Fernandez Hernandez, Xuelian Chen, Gerard J Nuovo, Jennifer S Carew, Ann F Mohrbacher, Paul A Fields, Peter Kuhn, Imran Siddiqi, Akil A Merchant, Kevin R Kelly
Comprehensive Single-Cell Immune Profiling Defines the Patient Multiple Myeloma Microenvironment Following Oncolytic Virus Therapy in a Phase 1b Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Trace M Jones, Claudia M Espitia, Aikseng Ooi, Julie E Bauman, Jennifer S Carew, Steffan T Nawrocki
Targeted CUL4A inhibition synergizes with cisplatin to yield long-term survival in models of head and neck squamous cell carcinoma through a DDB2-mediated mechanism. Cell death & disease 13 (4) (2022)